Jun 12, 2012 / Fact Sheets Fact sheet on MedPAC’s June 2012 congressionally requested report: Home infusion therapy Research Areas: Drugs, Devices, and Tests
Jun 01, 2012 / Chapters Chapter 6: Medicare coverage of and payment for home infusion therapy (June 2012 report) Research Areas: Drugs, Devices, and Tests
Jun 01, 2012 / Chapters Chapter 6 Appendixes: Medicare coverage of and payment for home infusion therapy (June 2012 report) Research Areas: Drugs, Devices, and Tests
Mar 15, 2012 / Reports March 2012 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans
Mar 15, 2012 / Press Releases MedPAC releases March 2012 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans
Mar 09, 2012 / Fact Sheets Fact sheet on March 2012 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans
Mar 09, 2012 / Transcripts March 2012 meeting transcript Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Post-Acute Care, Private Plans, Regional Issues
Mar 09, 2012 / Presentations Medicare coverage of and payment for home infusion therapy Research Areas: Drugs, Devices, and Tests, Private Plans
Mar 01, 2012 / Chapters Appendix A: Commissioners’ voting on recommendations (March 2012 report) Research Areas: Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Quality
Mar 01, 2012 / Chapters Chapter 13: Status report on Part D, with focus on beneficiaries with high drug spending (March 2012 report) Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Private Plans